Bisoprolol and Diltiazem: Drug Interaction Guide

Quick answer: This combination requires caution. Bisoprolol and Diltiazem can be used together with adjustments and monitoring.

Interaction severity: Moderate — caution required

How Bisoprolol interacts with Diltiazem

Bisoprolol reduces sympathetic cardiac stimulation, while diltiazem slows atrioventricular nodal conduction and reduces myocardial contractility. Combined use can cause bradycardia, heart block, or worsening heart failure.

What you should do

Use cautiously with baseline and follow-up heart rate, blood pressure, and ECG monitoring. Avoid in patients with significant conduction disease unless specialist supervised.

Key facts

Severity

Moderate — caution required

Mechanism

Bisoprolol reduces sympathetic cardiac stimulation, while diltiazem slows atrioventricular nodal conduction and reduces ...

Action

Use cautiously with baseline and follow-up heart rate, blood pressure, and ECG monitoring. Avoid in patients with signif...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Bisoprolol and Diltiazem together?

With caution. Use cautiously with baseline and follow-up heart rate, blood pressure, and ECG monitoring. Avoid in patients with significant conduction disease unless specialist supervised.

What is the severity of this interaction?

The interaction between Bisoprolol and Diltiazem is classified as Moderate — caution required. Bisoprolol reduces sympathetic cardiac stimulation, while diltiazem slows atrioventricular nodal conduction and reduces myocardial contractility. Combined use can cause bradycardia, heart block, or worsening heart failure.

What should I do if I'm prescribed both?

Use cautiously with baseline and follow-up heart rate, blood pressure, and ECG monitoring. Avoid in patients with significant conduction disease unless specialist supervised. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.